Dothan doctor helps develop FDA-approved treatment

Dothan doctor helps develop FDA-approved treatment

An FDA-approved drug is now on the market, and the doctor who led the research on it is right here in Dothan.
Dr. Kenneth Todd submitted the application to obtain FDA approval for Varithena, which was approved in September 2013 and released in August 2014.
Dr. Kenneth Todd submitted the application to obtain FDA approval for Varithena, which was approved in September 2013 and released in August 2014.
The Southeast Vein & Laser Center, located on Ross Clark Circle, treats patients with varicous veins, leg swelling, face veins and other conditions.
The Southeast Vein & Laser Center, located on Ross Clark Circle, treats patients with varicous veins, leg swelling, face veins and other conditions.
After 13 years of research and more than 1,300 patients, doctors say it could make a difference.  In fact, 50 patients were tested in Dothan alone.

"We were very fortunate to be not only part of the Vanish II study that brought Varithena to market, but to actually be the principal investigator to the Vanish II study, which is a multi-center study that went through a very rigorous FDA process to bring this drug to market," said Dr. Kenneth Todd, a vascular and lymphatic medicine specialist in Dothan, Alabama.

Dr. Todd led the research team that developed the injection Varithena, a commercial grade foam used for the treatment of veins.  Doctors say it's more effective and much safer than other treatments.  The Food and Drug Administration approved it in September 2013, and it was released a few days ago.

Todd says it's the first drug brought to market through a study done in Houston County, with a local doctor submitting the FDA application. 

"We're very proud of the fact that we have been able to be a part of this long ongoing process, because this is a product that will be an option for many people that don't have other options," Todd said.

Reports show half of all women 50 and older have a form of varicose veins, and more people die from blood clots than from AIDS and breast cancer combined, according to research.

"Most people in the general public don't realize that varicose vein disease can lead to clots in the leg, discoloration of the leg.  It's not just a cosmetic problem," said Todd.

In addition, Todd says Varithena will play a major role in the future treatment of these conditions, and he says the research done on the product will also help local medical students.

"With our new medical school, where research is a large part of their program, it's very nice to have had that program already get started by having a commercially available FDA-approved sclerosa that was created right here at home," Todd said.

He says ongoing research will help doctors apply the procedure to other types of therapy.

Doctors say you should never put off seeing a specialist for a formal diagnosis if you notice any symptoms, as it will help them detect any life-threatening issues.
Page: [[$index + 1]]
comments powered by Disqus